Literature DB >> 28391652

Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease.

P-D Katsoulos1, S C Chaintoutis2, C I Dovas2, Z S Polizopoulou2, G D Brellou3, E I Agianniotaki4, K E Tasioudi4, E Chondrokouki4, O Papadopoulos5, H Karatzias1, C Boscos1.   

Abstract

The present study was performed to investigate the clinical impact and certain virological and haematological parameters following immunization of cattle against lumpy skin disease (LSD). The study was conducted in a dairy cattle farm (215 animals), immunized with a Neethling strain-based live vaccine. Twenty-seven animals (14 lactating cows, four dry cows and nine calves) were randomly selected for repetitive blood and saliva samplings. An EvaGreen-based real-time PCR was designed to differentiate vaccine from field LSDVs. Vaccinated animals underwent examination for adverse reactions. Nodule samples were collected from two representative cases for histopathological testing and virus identification. Milk yield was calculated based on bulk-tank measurements of all lactating cows (79). Viral DNA was detected between days 6-15 post-vaccination (p.v.) at 63% of the sampled animals (17/27). Saliva and bulk-tank milk samples were LSDV-negative. Pronounced swelling was observed at injection sites of 12% of the immunized animals (26/215), starting at day 6 p.v., and was resolved after 2-4 days. Small-sized (<0.5 cm) cutaneous lumps were developed between days 8-18 p.v. at 9% of the vaccinated animals (19/215). These were observed in adult cows and not in calves/heifers. Resolution was observable 10 days post-development. The vaccine virus was also identified in nodules and injection-site aspirates. Haematological changes (e.g., lower leucocyte counts) were observed in cows and not in calves. Daily milk production was being reduced during the first 12 days p.v. LSD immunization of cows resulted in nodules and low viraemia levels. The fact that nodules and haematological changes were not observed in calves, along with the low viraemia, supports the reduced virulence of the Neethling vaccine strain. The characteristic nodules in vaccinated animals could allow clinical differentiation from those observed in LSD. The developed real-time PCR efficiently differentiates infected from vaccinated cattle, and should be further validated as a tool in LSD surveillance.
© 2017 Blackwell Verlag GmbH.

Entities:  

Keywords:  adverse reactions; cattle; haematology; immunization; lumpy skin disease; viraemia

Mesh:

Substances:

Year:  2017        PMID: 28391652     DOI: 10.1111/tbed.12646

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  9 in total

1.  Analysis and insights into recombination signals in lumpy skin disease virus recovered in the field.

Authors:  Alexander Sprygin; Yurii Babin; Yana Pestova; Svetlana Kononova; David B Wallace; Antoinette Van Schalkwyk; Olga Byadovskaya; Vyacheslav Diev; Dmitry Lozovoy; Alexander Kononov
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

2.  Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus.

Authors:  Janika Wolff; Tom Moritz; Kore Schlottau; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2020-12-23

Review 3.  Capripoxvirus Infections in Ruminants: A Review.

Authors:  Jihane Hamdi; Henry Munyanduki; Khalid Omari Tadlaoui; Mehdi El Harrak; Ouafaa Fassi Fihri
Journal:  Microorganisms       Date:  2021-04-23

4.  Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.

Authors:  Andrea M Spiri; Barbara Riond; Martina Stirn; Marilisa Novacco; Marina L Meli; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-07-30       Impact factor: 5.048

5.  Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.

Authors:  Serdar Uzar; Fahriye Sarac; Veli Gulyaz; Hakan Enul; Huseyin Yılmaz; Nuri Turan
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31

6.  High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate.

Authors:  Janika Wolff; Martin Beer; Bernd Hoffmann
Journal:  Vaccines (Basel)       Date:  2022-06-27

7.  Comparative Evaluation of Lumpy Skin Disease Virus-Based Live Attenuated Vaccines.

Authors:  Andy Haegeman; Ilse De Leeuw; Laurent Mostin; Willem Van Campe; Laetitia Aerts; Estelle Venter; Eeva Tuppurainen; Claude Saegerman; Kris De Clercq
Journal:  Vaccines (Basel)       Date:  2021-05-08

8.  Investigation of Post Vaccination Reactions of Two Live Attenuated Vaccines against Lumpy Skin Disease of Cattle.

Authors:  Zahra Bamouh; Jihane Hamdi; Siham Fellahi; Slimane Khayi; Mohammed Jazouli; Khalid Omari Tadlaoui; Ouafaa Fassi Fihri; Eeva Tuppurainen; Mehdi Elharrak
Journal:  Vaccines (Basel)       Date:  2021-06-08

9.  Experimental Infection and Genetic Characterization of Two Different Capripox Virus Isolates in Small Ruminants.

Authors:  Janika Wolff; Jacqueline King; Tom Moritz; Anne Pohlmann; Donata Hoffmann; Martin Beer; Bernd Hoffmann
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.